Advancing Biotherapeutic Intelligence

Gain access to a vault of next-generation antibody assets to streamline your path to the clinic

Contact Us

Taking aim and focused on clinical success

Talem Therapeutics is focused on the discovery and development of therapeutic antibodies targeting infectious diseases, immuno-oncology, oncology, ophthalmology and vascular disease. With direct access to world-class, expedited and end-to-end technologies, Talem accelerates preclinical development of novel therapeutic antibody treatments to the clinic through strategic alliances and partnerships.

Take your biotherapeutic programs to the next-level

Contact Us

Accelerating development of novel, high-priority, antibody therapies

Explore the innovative options available for out-licensing

Talem antibody experts match high value targets to fully vetted, premium therapeutic antibody programs.

Select from key targets for multiple indications, for licensing:

  • From early-stage (discovery level) to IND-enabling programs
  • A broad range of indications: immuno-oncology, oncology, ophthalmology, immunology, and infectious, and vascular diseases

See pipeline

Join us at an upcoming event

Join us at top-tier industry events below. Whether you’re seeking knowledge, partnerships, or simply looking for the latest innovations driving next-gen pharma solutions, let’s start the collaborative discussion. Don’t miss this opportunity to be part of the forefront of novel therapeutic advancements.

PEGS Boston
Boston, USA May 13-17
IPA booth # 307
Bio International
San Diego, USA Jun 4-8
 
Connect with us